Effect of intracarotid etoposide on opening the blood-brain barrier.
The effect of an intracarotid artery infusion of etoposide on blood-brain barrier (BBB) integrity was investigated in a rat model system. The external carotid arteries of Sprague-Dawley rats were catheterized in a retrograde manner. Etoposide in a dose range from 3.0 mg/kg to 22.5 mg/kg was infused into the internal carotid artery by this technique. BBB disruption was evaluated qualitatively by the appearance in the infused hemisphere of the systemically administered dye Evans blue and quantitatively by the ratio of counts of the technetium-labeled chelate of diethylenetriaminepentaacetic acid (99mTc-DTPA) in the infused to the noninfused hemisphere. Evidence of increased BBB permeability was seen at all doses of etoposide. Degree of BBB disruption increased with increasing doses of etoposide. The intracarotid infusion and subsequent BBB disruption were well tolerated. Further clinical trials employing the intracarotid administration of etoposide should be cognizant of the potential for BBB disruption.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D002342:Carotid Artery, External; D004305:Dose-Response Relationship, Drug; D005047:Etoposide / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D007261:Infusions, Intra-Arterial; D004369:Pentetic Acid; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D051381:Rats; D011919:Rats, Inbred Strains; D013667:Technetium; D016284:Technetium Tc 99m Pentetate
D005047:Etoposide; D013667:Technetium; D004369:Pentetic Acid; D011034:Podophyllotoxin; D016284:Technetium Tc 99m Pentetate